GS-100 ye recombinant AAV9 vector encoding the human NGLY1 gene. Yafuna ekifo ky'eddagala eritafa ku bantu okuva mu kitongole kya US Food and Drug Administration ne European Medicine Agency (EMA). Enzijanjaba eno era yafuna ekya FDA's rare paediatric disease designation mu 2021 ne fast track designation omwaka oguwedde.